These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Blood platelet disorders and thrombotic tendencies associated with Kawasaki disease]. Yamada K Nihon Rinsho; 1983 Sep; 41(9):2097-102. PubMed ID: 6663746 [No Abstract] [Full Text] [Related]
3. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791 [No Abstract] [Full Text] [Related]
4. Platelet immune complex interaction in the pathogenesis of Kawasaki disease. Levin M; Holland PC; Novelli V Prog Clin Biol Res; 1987; 250():227-37. PubMed ID: 3423040 [TBL] [Abstract][Full Text] [Related]
5. [Cancer and blood coagulation disorders]. Koshiro M Gan No Rinsho; 1989 Jan; Spec No():695-703. PubMed ID: 2915507 [No Abstract] [Full Text] [Related]
6. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--]. Mukaiyama H Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508 [No Abstract] [Full Text] [Related]
7. [Fuctional changes of various blood coagulation parameters during surgery]. Alánt O; Rubányi P Zentralbl Chir; 1974 Sep; 99(37):1164-71. PubMed ID: 4613065 [No Abstract] [Full Text] [Related]
8. Pleural effusion and disseminated intravascular coagulopathy: the rarely reported complications of kawasaki disease. Lee SH; Jeon YH; Yang HJ; Pyun BY Clin Pediatr (Phila); 2010 Jun; 49(6):598-600. PubMed ID: 20075032 [No Abstract] [Full Text] [Related]
9. Coagulation and thromboembolic complications in the nephrotic syndrome. Cameron JS Adv Nephrol Necker Hosp; 1984; 13():75-114. PubMed ID: 6433673 [No Abstract] [Full Text] [Related]
10. [Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation]. Shirahata A; Nakamura T; Asakura A Nihon Rinsho; 1983 Sep; 41(9):2103-10. PubMed ID: 6663747 [No Abstract] [Full Text] [Related]
11. [Platelet aggregation, erythrocyte filterability and changes of some blood coagulation parameters in subjects with chronic obstructive arteriopathy of the lower limbs]. Macchione C; Neirotti M; Longo F; Friziero M; Molaschi M; Poli L Minerva Cardioangiol; 1983; 31(7-8):433-8. PubMed ID: 6646445 [No Abstract] [Full Text] [Related]
12. The role of haemostatic mechanisms. Ratnoff OD Clin Haematol; 1981 Jun; 10(2):261-81. PubMed ID: 7032777 [No Abstract] [Full Text] [Related]
13. Kawasaki disease associated with serologic evidence of Rocky Mountain spotted fever. Headings DL; Santosham M Johns Hopkins Med J; 1981 Dec; 149(6):220-1. PubMed ID: 7311262 [No Abstract] [Full Text] [Related]
14. Platelets in Kawasaki patients: two different populations with different mitochondrial functions. Pietraforte D; Gambardella L; Marchesi A; Tarissi de Jacobis I; Villani A; Del Principe D; Malorni W; Straface E Int J Cardiol; 2014 Mar; 172(2):526-8. PubMed ID: 24491862 [No Abstract] [Full Text] [Related]
15. Kawasaki disease. Larson E West J Med; 1984 Jun; 140(6):929-30. PubMed ID: 6540009 [No Abstract] [Full Text] [Related]
16. [Plasma clotting system in neoplastic diseases]. Brajerski W Pol Tyg Lek; 1976 Jul; 31(27):1169-72. PubMed ID: 781641 [No Abstract] [Full Text] [Related]
17. Coagulation abnormalities in fulminant meningococcaemia. Mauger DC; Wilson WJ N Z Med J; 1971 Apr; 73(467):202-5. PubMed ID: 5280883 [No Abstract] [Full Text] [Related]